Lung Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Lung Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) [Phase 3]
A Phase 3 clinical trial (Chemo-IO ACCIO) is evaluating adding an immunotherapy agent to standard chemotherapy for non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients With Advanced Lung Adenocarcinoma [Phase 1]
A Phase 1 autologous tumor-infiltrating lymphocyte trial (GTE-001) for advanced lung adenocarcinoma has been terminated.
-
CLINICAL_TRIALS other · 2026-04-22Clinical Trial Update: Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer [Phase 2]
This Phase 2 clinical trial evaluates adding TRC102 to standard chemotherapy with pemetrexed plus cisplatin or carboplatin during radiation …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma [Phase 1, Phase 2]
A clinical trial update describing a phase 1/2 study of bemcentinib plus pacritinib in patients with advanced lung adenocarcinoma, currently…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer [Phase 2]
This Phase 2 clinical trial evaluates stereotactic body radiation therapy with or without nivolumab for patients with Stage I-IIA or recurre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative [Phase 2, Phase 3]
A phase 2/3 trial evaluating the addition of radiation therapy to standard immunotherapy with or without chemotherapy for PD-L1–negative adv…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm [NA]
A clinical trial evaluating segmentectomy versus lobectomy for small lung adenocarcinoma (≤2 cm) is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma [Phase 1]
Phase 1 study evaluating tumor-treating fields (TTFields) in patients with lung adenocarcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Pathogenic Variants in Genes Associated With Lung Adenocarcinoma
This Clinical Trial Update reports on a study investigating pathogenic variants in genes associated with lung adenocarcinoma. The trial is c…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases [Phase 3]
Phase 3 clinical trial investigating bevacizumab plus fractionated stereotactic radiotherapy (FSRT) versus hippocampus-avoidant whole-brain …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer [Phase 3]
Clinical trial update for a Phase 3 study of nivolumab and ipilimumab with or without local consolidation therapy in patients with Stage IV …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic-predominant Growth Lung Adenocarcinoma [NA]
This clinical trial investigates whether a low-glucose/high-fat dietary regimen improves the diagnostic accuracy of 2-[18F]FDG PET/CT for le…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating a gene-modified immune cell therapy after a conditioning regimen for metastatic melanoma and other metas…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma [Phase 4]
Phase 4 clinical trial comparing pemetrexed-free versus pemetrexed-based immunochemotherapy in metastatic TTF-1 negative lung adenocarcinoma…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
A clinical trial sponsored by Fu Jen Catholic University is studying biomarkers in pleural effusion from patients with lung adenocarcinoma, …
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Engagement of Veterans With Lung Cancer [NA]
A clinical trial update indicates the study sponsored by Palo Alto Veterans Institute for Research is currently recruiting veterans with var…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors [Phase 1, Phase 2]
AZD5335 is being studied in Phase 1/2a as both a single-agent therapy and in combination therapy for solid tumors, with recruitment ongoing.…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer [NA]
A recruiting clinical trial is evaluating partial tumor irradiation in combination with immunotherapy for unresectable lung cancer, includin…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma [EARLY_Phase 1]
This early-phase 1 trial evaluates the safety of dapagliflozin given before surgery in patients with Stage IA lung adenocarcinoma (a form of…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer [NA]
A clinical trial sponsored by Ohio State University Comprehensive Cancer Center is recruiting to test a protocol for improving survival in p…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC [Phase 2]
Phase 2 study evaluating QL1706 plus chemotherapy and bevacizumab in PD-L1 ≥50% non-squamous non-small cell lung cancer; the trial is curren…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC
A clinical trial to evaluate whether peripheral blood ETASTs can predict the efficacy of chemoimmunotherapy in non-small cell lung cancer. T…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib. [Phase 2]
A Phase 2 clinical trial is evaluating intrathecal pemetrexed for leptomeningeal metastasis from lung adenocarcinoma that progressed after O…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma [Phase 3]
A Phase 3 clinical trial evaluating whether adding cryoablation to first-line pembrolizumab plus pemetrexed–carboplatin improves outcomes in…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib
This study is recruiting to evaluate Iruplinalkib in ALK-positive advanced non-small cell lung cancer after progression on Lorlatinib, incor…